Evidence map›Paper›PMID 32550603›Full record

ArticleJVS-vascular science2020

Circulating exosomes from patients with peripheral artery disease influence vascular cell migration and contain distinct microRNA cargo.

Thomas A Sorrentino, Phat Duong, Laura Bouchareychas, Mian Chen, Allen Chung, Melinda S Schaller, Adam Oskowitz, Robert L Raffai, Michael S Conte

Open access · goldAbstract read
In one paragraph

Article in JVS-vascular science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Atherosclerosis and Its Related Laboratory Biomarkers.International journal of molecular sciences · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Exosomal microRNAs in diabetic heart disease.Cardiovascular diabetology · 2022
    Review
  19. IL-4 polarized human macrophage exosomes control cardiometabolic inflammation and diabetes in obesity.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Thomas A SorrentinoDepartment of Vascular and Endovascular Surgery, University of California.
Phat DuongSan Francisco Veterans Affairs Medical Center.
Laura BouchareychasSan Francisco Veterans Affairs Medical Center.
Mian ChenDepartment of Vascular and Endovascular Surgery, University of California.
Allen ChungSan Francisco Veterans Affairs Medical Center.
Melinda S SchallerDepartment of Vascular and Endovascular Surgery, University of California.
Adam OskowitzDepartment of Vascular and Endovascular Surgery, University of California.
Robert L RaffaiDepartment of Vascular and Endovascular Surgery, University of California.
Michael S ConteDepartment of Vascular and Endovascular Surgery, University of California.
University of California, San Francisco · USSan Francisco VA Medical Center · US

Funding

Specialized lipid mediators and mechanisms of resolution in vascular injuryR01HL119508 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CONTE, MICHAEL S · 2013 to 2016
$1.5M
Hyperglycemia and MicroRNA Dysregulation of Inflammation in AtherosclerosisR01HL133575 · NHLBI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI RAFFAI, ROBERT · 2016 to 2019
$1.5M
Exosomes in the Pathogenesis of Diabetic Atherosclerosis & its Treatment OpportunitiesI01BX003928 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI Robert Raffai · 2019 to 2026
–
BLRD VA I01 BX003928NHLBI NIH HHS R01 HL119508NHLBI NIH HHS R01 HL133575
6 · The paper itself

Abstract

objectivePeripheral artery disease (PAD) is a chronic condition characterized by inflammation. Emerging literature suggests that circulating exosomes and their microRNA (miRNA) contents may influence atherosclerosis and vascular remodeling. We hypothesize that circulating exosomes in patients with PAD directly modulate vascular cell phenotype and contain proinflammatory miRNAs.

methodsExosomes (particle size, 30-150 nm) were isolated from plasma of healthy individuals (n = 6), patients with mild PAD (mPAD; median Rutherford class, 2.5; n = 6), and patients with severe PAD (sPAD; median Rutherford class, 4; n = 5). Exosome identity, size, and concentration were determined by Western blot and nanoparticle tracking analysis. Human vascular smooth muscle cell (VSMC) and endothelial cell (EC) migration was assessed by a standard wound closure assay after exposure to exosome preparations. Monocyte-derived macrophages isolated from healthy volunteers were exposed to exosome preparations, and targeted gene expression was analyzed using quantitative polymerase chain reaction. Exosome miRNA cargos were isolated, and a panel of defined, vascular-active miRNAs was assessed by quantitative polymerase chain reaction.

resultsThere was no difference in overall exosome particle concentration or size between the three groups (one-way analysis of variance [ANOVA],

conclusionsCirculating exosomes from individuals with PAD exert in vitro functional effects on VSMCs and ECs that may promote adverse vessel remodeling. Exosomes from healthy individuals, mPAD patients, and sPAD patients contain distinct signatures of immune-regulatory miRNA. Together these data suggest that the proinflammatory cargo of circulating exosomes correlates with atherosclerosis severity in PAD patients and could influence vascular injury and repair. (JVS: Vascular Science 2020;1:28-41.). CLINICAL RELEVANCE: Exosomes and their cargo have been implicated in several vascular remodeling processes including atherosclerosis, angiogenesis, and neointimal hyperplasia. In this study, we demonstrate that circulating exosomes from individuals with peripheral artery disease exert in vitro effects on vascular cells that may adversely affect vessel remodeling. Moreover, these exosomes contain elevated levels of vascular-active microRNA. Our results suggest that exosomes may serve as both biomarkers and effectors of vascular disease in patients with peripheral artery disease and motivate further investigation into the role of exosomes and their contents in aberrant remodeling in vascular diseases.

Indexed as

ExosomemiRNAPeripheral artery diseaseRestenosisVascular remodeling

Identifiers

PMID32550603
PMCPMC7299234
OpenAlexW3007423837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.